公司資料
Arcturus Therapeutics Holdings Inc. 股價、新聞與催化劑
- 股票代碼:
- ARCT
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
8.14 USD (-1.09%)
收盤價
最後更新: 2026年8月17日
217M USD
市值
股價為何變動
As of Aug 17, 2026, ARCT closed down 1.09% at $8.14. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Arcturus Therapeutics is an RNA medicines company focused on mRNA and self-amplifying RNA technologies. Its story is built around platform science that aims to produce vaccines and therapeutics across multiple disease areas.
所在地與產業分類
Arcturus is headquartered in the United States and listed on NASDAQ. It sits in platform biotechnology with a strong RNA-technology identity.
商業模式特徵
The company depends on platform validation, clinical progress, and the ability to convert RNA science into durable product revenue. Investors watch vaccine or therapeutic data, partnerships, and manufacturing capability.
生技產業定位
Arcturus occupies a platform-RNA niche within biotech. It is sensitive to whether self-amplifying RNA can create differentiated therapeutic value beyond the first wave of products.
未來催化劑
- Arcturus’s catalysts are mRNA-platform updates, vaccine and therapeutic development, and any partnership or clinical step that keeps the platform credible. The company still needs human proof.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。